Across TCGA pan-cancer cohorts, ATF7-NPFF Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated ATF7-NPFF data layer compared with 24 for mass-spec protein.
The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher ATF7-NPFF Mutation is associated with worse disease-free survival. In most high-consensus cancer types, elevated ATF7-NPFF expression acts as an unfavorable survival marker.
UCEC are the cancer types where ATF7-NPFF Mutation most reproducibly stratifies survival.